136 related articles for article (PubMed ID: 10680745)
1. Concanavalin A-induced hepatitis in mice is prevented by interleukin (IL)-10 and exacerbated by endogenous IL-10 deficiency.
Di Marco R; Xiang M; Zaccone P; Leonardi C; Franco S; Meroni P; Nicoletti F
Autoimmunity; 1999 Oct; 31(2):75-83. PubMed ID: 10680745
[TBL] [Abstract][Full Text] [Related]
2. Murine concanavalin A-induced hepatitis is prevented by interleukin 12 (IL-12) antibody and exacerbated by exogenous IL-12 through an interferon-gamma-dependent mechanism.
Nicoletti F; Di Marco R; Zaccone P; Salvaggio A; Magro G; Bendtzen K; Meroni P
Hepatology; 2000 Oct; 32(4 Pt 1):728-33. PubMed ID: 11003616
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of concanavalin A-induced hepatic injury of mice by bacterial lipopolysaccharide via the induction of IL-6 and the subsequent reduction of IL-4: the cytokine milieu of concanavalin A hepatitis.
Nishikage T; Seki S; Toyabe S; Abo T; Kagata Y; Iwai T; Hiraide H
J Hepatol; 1999 Jul; 31(1):18-26. PubMed ID: 10424279
[TBL] [Abstract][Full Text] [Related]
4. Critical involvement of interferon gamma in the pathogenesis of T-cell activation-associated hepatitis and regulatory mechanisms of interleukin-6 for the manifestations of hepatitis.
Mizuhara H; Uno M; Seki N; Yamashita M; Yamaoka M; Ogawa T; Kaneda K; Fujii T; Senoh H; Fujiwara H
Hepatology; 1996 Jun; 23(6):1608-15. PubMed ID: 8675184
[TBL] [Abstract][Full Text] [Related]
5. Effects of the Japanese herbal medicine 'Inchinko-to' (TJ-135) on concanavalin A-induced hepatitis in mice.
Yamashiki M; Mase A; Arai I; Huang XX; Nobori T; Nishimura A; Sakaguchi S; Inoue K
Clin Sci (Lond); 2000 Nov; 99(5):421-31. PubMed ID: 11052923
[TBL] [Abstract][Full Text] [Related]
6. Strain difference in the induction of T-cell activation-associated, interferon gamma-dependent hepatic injury in mice.
Mizuhara H; Kuno M; Seki N; Yu WG; Yamaoka M; Yamashita M; Ogawa T; Kaneda K; Fujii T; Senoh H; Fujiwara H
Hepatology; 1998 Feb; 27(2):513-9. PubMed ID: 9462651
[TBL] [Abstract][Full Text] [Related]
7. Glutathione peroxidase 1 deficiency attenuates concanavalin A-induced hepatic injury by modulation of T-cell activation.
Lee DH; Son DJ; Park MH; Yoon DY; Han SB; Hong JT
Cell Death Dis; 2016 Apr; 7(4):e2208. PubMed ID: 27124582
[TBL] [Abstract][Full Text] [Related]
8. Production and role of interleukin-10 in concanavalin A-induced hepatitis in mice.
Louis H; Le Moine O; Peny MO; Quertinmont E; Fokan D; Goldman M; Devière J
Hepatology; 1997 Jun; 25(6):1382-9. PubMed ID: 9185757
[TBL] [Abstract][Full Text] [Related]
9. Protection from concanavalin A (Con A)-induced T cell-dependent hepatic lesions and modulation of cytokine release in mice by sodium fusidate.
Nicoletti F; Beltrami B; Raschi E; Di Marco R; Magro G; Grasso S; Bendtzen K; Fiorelli G; Meroni PL
Clin Exp Immunol; 1997 Dec; 110(3):479-84. PubMed ID: 9409654
[TBL] [Abstract][Full Text] [Related]
10. Bimodal role of endogenous interleukin-6 in concanavalin A-induced hepatitis in mice.
Tagawa Y; Matthys P; Heremans H; Dillen C; Zaman Z; Iwakura Y; Billiau A
J Leukoc Biol; 2000 Jan; 67(1):90-6. PubMed ID: 10648002
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic administration of Y-40138, a multiple cytokine modulator, inhibits concanavalin A-induced hepatitis in mice.
Fukuda T; Mogami A; Hisadome M; Komatsu H
Eur J Pharmacol; 2005 Oct; 523(1-3):137-42. PubMed ID: 16236280
[TBL] [Abstract][Full Text] [Related]
12. Role of CpG ODN in concanavalin A-induced hepatitis in mice.
Abe K; Ohira H; Kobayashi H; Rai T; Saito H; Takahashi A; Sato Y
Fukushima J Med Sci; 2005 Jun; 51(1):41-9. PubMed ID: 16167672
[TBL] [Abstract][Full Text] [Related]
13. Prevention by rolipram of concanavalin A-induced T-cell-dependent hepatitis in mice.
Xiang M; Zaccone P; Di Marco R; Magro G; Di Mauro M; Beltrami B; Meroni PL; Nicoletti F
Eur J Pharmacol; 1999 Feb; 367(2-3):399-404. PubMed ID: 10079016
[TBL] [Abstract][Full Text] [Related]
14. Therapeutic advantage of anti-VAP-1 over anti-α4 integrin antibody in concanavalin a-induced hepatitis.
Lee WY; Salmi M; Kelly MM; Jalkanen S; Kubes P
Hepatology; 2013 Oct; 58(4):1413-23. PubMed ID: 23686782
[TBL] [Abstract][Full Text] [Related]
15. CD49a promotes T-cell-mediated hepatitis by driving T helper 1 cytokine and interleukin-17 production.
Chen Y; Peng H; Chen Y; Wei H; Sun R; Tian Z
Immunology; 2014 Mar; 141(3):388-400. PubMed ID: 24164540
[TBL] [Abstract][Full Text] [Related]
16. NO-aspirin protects from T cell-mediated liver injury by inhibiting caspase-dependent processing of Th1-like cytokines.
Fiorucci S; Santucci L; Antonelli E; Distrutti E; Del Sero G; Morelli O; Romani L; Federici B; Del Soldato P; Morelli A
Gastroenterology; 2000 Feb; 118(2):404-21. PubMed ID: 10648469
[TBL] [Abstract][Full Text] [Related]
17. Essential pathogenetic role for interferon (IFN-)gamma in concanavalin A-induced T cell-dependent hepatitis: exacerbation by exogenous IFN-gamma and prevention by IFN-gamma receptor-immunoglobulin fusion protein.
Nicoletti F; Zaccone P; Xiang M; Magro G; Di Mauro M; Di Marco R; Garotta G; Meroni P
Cytokine; 2000 Apr; 12(4):315-23. PubMed ID: 10805211
[TBL] [Abstract][Full Text] [Related]
18. Beraprost sodium, a prostacyclin (PGI) analogue, ameliorates concanavalin A-induced liver injury in mice.
Ohta S; Nakamuta M; Fukushima M; Kohjima M; Kotoh K; Enjoji M; Nawata H
Liver Int; 2005 Oct; 25(5):1061-8. PubMed ID: 16162167
[TBL] [Abstract][Full Text] [Related]
19. Macrophage inflammatory protein-2 induced by TNF-alpha plays a pivotal role in concanavalin A-induced liver injury in mice.
Nakamura K; Okada M; Yoneda M; Takamoto S; Nakade Y; Tamori K; Aso K; Makino I
J Hepatol; 2001 Aug; 35(2):217-24. PubMed ID: 11580144
[TBL] [Abstract][Full Text] [Related]
20. Alpha-lipoic acid protects mice against concanavalin A-induced hepatitis by modulating cytokine secretion and reducing reactive oxygen species generation.
Fei M; Xie Q; Zou Y; He R; Zhang Y; Wang J; Bo L; Li J; Deng X
Int Immunopharmacol; 2016 Jun; 35():53-60. PubMed ID: 27018751
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
